- Home
- PANL vs GNFT Comparison
PANL vs GNFT Comparison
Compare PANL & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PANL
- GNFT
- Stock Information
- Founded
- PANL 1996
- GNFT 1999
- Country
- PANL United States
- GNFT France
- Employees
- PANL N/A
- GNFT N/A
- Industry
- PANL Marine Transportation
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PANL Consumer Discretionary
- GNFT Health Care
- Exchange
- PANL Nasdaq
- GNFT Nasdaq
- Market Cap
- PANL 257.0M
- GNFT 190.6M
- IPO Year
- PANL N/A
- GNFT 2019
- Fundamental
- Price
- PANL $4.90
- GNFT $3.71
- Analyst Decision
- PANL Strong Buy
- GNFT Strong Buy
- Analyst Count
- PANL 1
- GNFT 1
- Target Price
- PANL N/A
- GNFT $13.00
- AVG Volume (30 Days)
- PANL 216.3K
- GNFT 7.9K
- Earning Date
- PANL 11-12-2024
- GNFT 09-19-2024
- Dividend Yield
- PANL 8.11%
- GNFT N/A
- EPS Growth
- PANL N/A
- GNFT N/A
- EPS
- PANL 0.47
- GNFT 0.47
- Revenue
- PANL $521,238,386.00
- GNFT $86,225,222.00
- Revenue This Year
- PANL $8.04
- GNFT $155.44
- Revenue Next Year
- PANL $13.05
- GNFT N/A
- P/E Ratio
- PANL $10.44
- GNFT $7.55
- Revenue Growth
- PANL 5.23
- GNFT 175.45
- 52 Week Low
- PANL $4.82
- GNFT $3.31
- 52 Week High
- PANL $9.53
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- PANL 29.61
- GNFT 33.06
- Support Level
- PANL $4.82
- GNFT $3.63
- Resistance Level
- PANL $5.05
- GNFT $3.94
- Average True Range (ATR)
- PANL 0.17
- GNFT 0.13
- MACD
- PANL -0.01
- GNFT 0.03
- Stochastic Oscillator
- PANL 9.88
- GNFT 19.17
About PANL Pangaea Logistics Solutions Ltd.
Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk transportation services. It transports drybulk cargos including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The firm's services include cargo loading, cargo discharge, vessel chartering, voyage planning and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.